Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lun...
Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
About this item
Full title
Author / Creator
Wen, Lei , Zhen, Junjie , Shan, Changguo , Lai, Mingyao , Hong, Weiping , Wang, Hui , Ye, Mingting , Yang, Yanying , Li, Shaoqun , Zhou, Zhaoming , Zhou, Jiangfen , Hu, Qingjun , Li, Juan , Tian, Xuwei , Chen, Longhua , Cai, Linbo , Xie, Zhanhong and Zhou, Cheng
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The aim of this study was to evaluate the efficacy and safety of osimertinib for the treatment of leptomeningeal metastases (LM) from epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC).
We conducted a systematic review and meta-analysis to aggregate the clinical outcomes of patients with LM from EGFR-mutant NSCLC t...
Alternative Titles
Full title
Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_454a4a5e0787433c981edeea599115a0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_454a4a5e0787433c981edeea599115a0
Other Identifiers
ISSN
2047-783X,0949-2321
E-ISSN
2047-783X
DOI
10.1186/s40001-023-01219-y
